Report Overview:
The Global Antibody Drug Conjugates Market achieved a valuation of $4.75 Billion in 2022 and is anticipated to exceed $18.84 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 18.8% during the forecast period from 2024 to 2032.
Key Market Players:
Takeda Pharmaceutical Company Ltd. (Japan), F. Hoffmann-La Roche Ltd. (US), Pfizer Inc. (US),...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek